Renal cell carcinoma as a cause of end-stage renal disease in the United States: Patient characteristics and survival

Kidney International

Volumn 64, Issue 1, 2003, Pages 247-253

  Stiles, Kevin P ^b   Moffatt, Michael J ^b   Agodoa, Lawrence Y ^b   Swanson, S John ^b   Abbott, Kevin C ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Age; Caucasian; Complications; Dialysis; Male; Nephrectomy; Renal cell carcinoma; Transplantation; USRDS

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONFIDENCE INTERVAL; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHRECTOMY; PRIORITY JOURNAL; SURVIVAL; UNITED STATES;

EID: 0038468807     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00060.x     Document Type: Article

References (45)

1. STEWART JH, BUCCIANTI G, AGODOA LY, et al: Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: Analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14:197-207, 2003
2. CHOW WH, DEVESA SS, WARREN JL, FRAUMENI JF, JR: Rising incidence of renal cell cancer in the United States. JAMA 281:1628-1631, 1999
3. DENTON MD, MAGEE CC, OVUWORIE C, et al: Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: A pathologic analysis. Kidney Int 61:2201-2209, 2002
4. CHEN KS, LAI MK, HUANG CC, et al: Urologic cancers in uremic patients. Am J Kidney Dis 25:694-700, 1995
5. SHINGLETON WB, BLALOCK J, CLARK J, BIGLER SA: Renal cell carcinoma in native kidneys of patients with end stage renal disease. J Miss State Med Assoc 39:86-89, 1998
6. LI MK, CHOY DK, YIP SK: Renal cell carcinoma in patients with chronic renal failure. Ann Acad Med Singapore 28:512-515, 1999
7. ISHIKAWA I: Renal cell carcinomas in patients on long-term hemodialysis. Contrib Nephrol 128:28-44, 1999
8. th Edition, Elsevier Science, Philadelphia, 2002, pp 2714
9. MCKIERNAN J, SIMMONS R, KATZ J, RUSSO P: Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59:816-820, 2002
10. DAGNONE AJ, YOUNG ID, MORALES A: Metastatic renal cell carcinoma regression after nephrectomy and BCG immunotherapy. Can J Urol 6:749-750, 1999
11. BLACK J, ROTELLAR C, RAKOWSKI TA, WINCHESTER JF: Bilateral nephrectomy and dialysis as an option for patients with bilateral renal cancer. Nephron 49:150-153, 1988
12. REINBERG Y, MATAS A, MANIVEL C, et al: Outcome of renal transplantation or dialysis in patients with a history of renal cancer. Cancer 70:1564-1567, 1992
13. PECES R, ALVAREZ-NAVASCUES R: Unilateral renal cell carcinoma with coexistent renal disease: a rare cause of end-stage renal disease. Nephrol Dial Transplant 16:291-294, 2001
14. KASISKE BL, RAMOS EL, GASTON RS, et al: The evaluation of renal transplant candidates: Clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 6:1-34, 1995
15. LONGENECKER JC, CORESH J, KLAG MJ, et al: Validation of comorbid conditions on the end-stage renal disease medical evidence report: The CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol 11:520-529, 2000
16. SZKLO M, NIETO FJ: Stratification and adjustment: Multivariate analysis in epidemiology, in Epidemiology: Beyond the Basics, Gaithersburg, MD, Aspen Publishers, 2000, pp 257
17. FATICA RA, PORT FK, YOUNG EW: Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis 37:1184-1190, 2001
18. SHIH LY, WANG ML, FU JF: Simultaneous occurrence of multiple aetiologies of polycythaemia: Renal cell carcinoma, sleep apnoea syndrome, and relative polycythaemia in a smoker with masked polycythaemia rubra vera. J Clin Pathol 53:561-564, 2000
19. NOGUCHI Y, GOTO T, YUFU Y, et al: Gene expression of erythropoietin in renal cell carcinoma. Intern Med 38:991-994, 1999
20. CLARK D, KERSTING R, ROJIANI AM: Erythropoietin immunolocalization in renal cell carcinoma. Mod Pathol 11:24-28, 1998
21. ABBOTT KC, AGODOA LY: Polycystic kidney disease in patients on the renal transplant waiting list: Trends in hematocrit and survival. BMC Nephrol 3:7, 2002
22. DAGNONE AJ, YOUNG ID, MORALES A: Metastatic renal cell carcinoma regression after nephrectomy and BCG immunotherapy. Can J Urol 6:749-750, 1999
23. LJUNGBERG B, LANDBERG G, ALAMDARI FI: Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy. Scand J Urol Nephrol 34:246-251, 2000
24. YAMADA Y, HONDA N, MITSUI K, et al: Clinical features of renal cell carcinoma less than 25 millimeters in diameter. Int J Urol 9:663-667, 2002
25. BRAZDA E, OFNER D, RIEDMANN B, et al: The effect of nephrectomy on the outcome of renal transplantation in patients with polycystic kidney disease. Ann Transplant 1:15-18, 1996
26. GLASSMAN DT, NIPKOW L, BARTLETT ST, JACOBS SC: Bilateral nephrectomy with concomitant renal graft transplantation for autosomal dominant polycystic kidney disease. J Urol 164:661-664, 2000
27. KNISPEL HH, KLAN R, OFFERMANN G, MILLER K: Transplantation in autosomal dominant polycystic kidney disease without nephrectomy. Urol Int 56:75-78, 1996
28. HASAN WA, AL-BAREEQ R, DURAZI M, AL-MUTTAWA S: Simultaneous renal cell carcinoma of the kidney and transitional cell carcinoma of the bladder. Can J Urol 9:1565-1567, 2002
29. GHAVAMIAN R, CHEVILLE JC, LOHSE CM, et al: Renal cell carcinoma in the solitary kidney: An analysis of complications and outcome after nephron sparing surgery. J Urol 168:454-459, 2002
30. FIORI E, DE CESARE A, GALATI G, et al: Prognostic significance of primary-tumor extension, stage and grade of nuclear differentiation in patients with renal cell carcinoma. J Exp Clin Cancer Res 21:229-232, 2002
31. PATARD JJ, RODRIGUEZ A, RIOUX-LECLERCQ N, et al: Prognostic significance of the mode of detection in renal tumours. BJU Int 90:358-363, 2002
32. MELISSOURGOS N, DOUMAS K, MESSINI I, et al: Multicentricity in renal cell carcinoma: Can primary tumor location serve as a co-determinant of surgical treatment? Eur Urol 41:262-266, 2002
33. ELOUBEIDI MA, JHALA D, CHHIENG DC, et al: Multiple late asymptomatic pancreatic metastases from renal cell carcinoma: Diagnosis by endoscopic ultrasound-guided fine needle aspiration biopsy with immunocytochemical correlation. Dig Dis Sci 47:1839-1842, 2002
34. ZISMAN A, PANTUCK AJ, CHAO DH, et al: Renal cell carcinoma with tumor thrombus: is cytoreductive nephrectomy for advanced disease associated with an increased complication rate? J Urol 168:962-967, 2002
35. POPE JC, KOCH MO, BLUTH RF: Renal cell carcinoma in patients with end-stage renal disease: A comparison of clinical significance in patients receiving hemodialysis and those with renal transplants. Urology 44:497-501, 1994
36. BLAGG CR: The US Renal Data System and the Case-Mix Severity Study. Am J Kidney Dis 21:106-108, 1993
37. SCHEINMAN JI, ALEXANDER M, CAMPBELL ED, et al: Transplantation for primary hyperoxaluria in the USA. Nephrol Dial Transplant 10:42-46, 1995
38. ABBOTT KC, HYPOLITE IO, AGODOA LY: Sickle cell nephropathy at end-stage renal disease in the United States: Patient characteristics and survival. Clin Nephrol 58:9-15, 2002
39. O'KEEFE SC, MARSHALL FF, ISSA MM, et al: Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J Urol 168:1378-1380, 2002
40. SCHAFER GE, REHBEIN C, STIEGLER T, HAMPL H: Renal anemia and its hemodynamic response - Findings invasively determined over a period of 20 years. Clin Nephrol 58:S52-57, 2002
41. SUNDER-PLASSMANN G, HORL WH: Effect of erythropoietin on cardiovascular diseases. Am J Kidney Dis 38:S20-25, 2001
42. CHEUK W, LO ES, CHAN AK, CHAN JK: Atypical epithelial proliferations in acquired renal cystic disease harbor cytogenetic aberrations. Hum Pathol 33:761-765, 2002
43. BOSMAN C, DIOMEDI CAMASSEI F, DEL NONNO F, et al: Acquired cystic kidney disease following long-term peritoneal dialysis for congenital nephrotic syndrome. Scand J Urol Nephrol 36:83-86, 2002
44. LOHSE CM, BLUTE ML, ZINCKE H, et al: Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients. Am J Clin Pathol 118:877-886, 2002
45. FRANK I, BLUTE ML, CHEVILLE JC, et al: An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score. J Urol 168:2395-2400, 2002